Webinar Recording: When Things Go Wrong – Sip Safely
In this episode, moderator Bethany Moore of The GMP Collective is joined by Diana Eberlein of Coalition for Adult Beverage Alternatives (CABA) and Ben Larson of Vertosa.
In this episode, moderator Bethany Moore of The GMP Collective is joined by Diana Eberlein of Coalition for Adult Beverage Alternatives (CABA) and Ben Larson of Vertosa.
In this episode, moderator Bethany Moore of The GMP Collective is joined by Ernest Toney, BIPOCANN, and Dominique Mendiola of CO MED and President of CANNRA.
Become an exclusive sponsor for our monthly webinar series and showcase your brand to a targeted audience of industry professionals! Sponsor 3 consecutive 1-hour episodes for $3,000. The package includes: Placement of your sponsor blurb, logo, and website link in our promotional emails, maximizing visibility among our subscriber base. Prominent display of your logo on digital marketing materials for LinkedIn, ensuring exposure to a wider professional network. Special acknowledgment as the webinar sponsor during the opening remarks, with a “Thank you to today’s sponsor” shoutout, featured in the on-demand recording accessible to viewers post-event. Elevate your brand and support valuable
Publication dIn this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Gillian Schauer of CANNRA, and Martin Woodbridge of Woodbridge Research.
In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Gillian Schauer of CANNRA, and Martin Woodbridge of Woodbridge Research.
In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Jini Glaros of Modern Canna Labs, andd Dylan Wilks of Orange Photonics.
In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.
We all make mistakes. Small ones. Big ones. Some have immediate implications (you forget to look both ways and pull out of an intersection only to end up in a car accident), while some implications aren’t realized until weeks or months later (a hinge or nut is not tightened to the right specification and comes loose over time before falling off). When it’s in your home, the impact may be minor and of short duration, but when it happens on a manufacturing line, the impacts can be significant. But all too often, these mistakes go unnoticed and undetected. How can
In this episode, moderator Bethany Moore of The GMP Collective is joined by Diana Eberlein of Coalition for Adult Beverage Alternatives (CABA) and Ben Larson of Vertosa.
In this episode, moderator Bethany Moore of The GMP Collective is joined by Ernest Toney, BIPOCANN, and Dominique Mendiola of CO MED and President of CANNRA.
Become an exclusive sponsor for our monthly webinar series and showcase your brand to a targeted audience of industry professionals! Sponsor 3 consecutive 1-hour episodes for $3,000. The package includes: Placement of your sponsor blurb, logo, and website link in our promotional emails, maximizing visibility among our subscriber base. Prominent display of your logo on digital marketing materials for LinkedIn,
Publication dIn this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Gillian Schauer of CANNRA, and Martin Woodbridge of Woodbridge Research.
In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Gillian Schauer of CANNRA, and Martin Woodbridge of Woodbridge Research.
In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Jini Glaros of Modern Canna Labs, andd Dylan Wilks of Orange Photonics.
In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.
We all make mistakes. Small ones. Big ones. Some have immediate implications (you forget to look both ways and pull out of an intersection only to end up in a car accident), while some implications aren’t realized until weeks or months later (a hinge or nut is not tightened to the right specification and comes loose over time before falling off). When it’s in your home, the impact may be minor and of short duration, but when it happens on a manufacturing line, the impacts can be significant. But all too often, these mistakes go unnoticed and undetected. How can you fix a problem if you don’t know what caused it in the first place?